[Billing problems and ethical questions. Personalized cancer therapy: great expectations but much is still uncertain].
Ilse
I
Schlingensiepen
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood; D004992:Ethics, Medical; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000941:ethics*; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D057285:Precision Medicine / Q000941:ethics*; D012051:Reimbursement Mechanisms / Q000941:ethics*; D040841:Resource Allocation / Q000941:ethics; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor